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Gender differences in STEMI patients treated by primary PCI
Philippe Degrell, Olivier Barthelemy, Thibault Petroni, Johanne Silvain,
Remi Choussat, Jean-Philippe Collet, Gerard Helft, Pierre-Louis Michel,
Gilles Montalescot, Claude Le Feuvre
Hôpital La Pitié-Salpêtrière, Cardiologie, Paris, France
Purpose: To compare one-year outcomes after primary percutaneous cor-
onary intervention (PCI) for STEMI, according to gender. 
Methods: Consecutive women referred to our Cath-Lab for primary PCI
for STEMI <24H from August 2007 to January 2011 were included. They
were compared to men undergoing primary PCI during the same period and
matched for age and diabetes. The occurrence of all cause mortality, TVR and
MACCE (Death, MI or stroke) were assessed at 12 months. 
Results: Among 787 consecutive STEMI patients, 182 (23.1%) were women.
They were matched for age and diabetes with 182 men. Mean age was 69±15
years, 18% had diabetes, 48% had multi-vessel coronary disease, 86% had radial
PCI. After matching, clinical and procedural characteristics were comparable,
except for an excess of renal failure (creatinin clearance 73±40 vs. 82±38 ml/min,
p=0.041) and cardiogenic shock (15% vs. 7%, p=0.017) in women. Women had
also less radial PCI (81% vs. 90%, p=0.024) than men. Follow-up was completed
for 99.7% of the patients. At one year, 74 (20.4%) patients died, 26 (7.2%) had
TVR and 94 (22.6%) had MACCE. Clinical outcomes were not statistically dif-
ferent between women and men after matching (Figure). After exclusion of
patients with cardiogenic shock (10.7%) and/or out-of-hospital cardiac arrest
(6.6%), the rates of death (11.3% vs. 11.8%, p>0.999) and MACCE (13.3% vs.
14.9%, p=0.746) remain comparable in women and men, respectively. 
Conclusions: After matching for age and diabetes, women have compa-
rable 12 month outcomes after primary PCI for STEMI compared to men,
despite a higher risk profile.
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SYNTAX score in diabetic patients in the acute phase of myocardial
infarction
Abdelghani Derrou (1), Sophie Richet (1), Aurélie Gudjoncik (1), Carole
Richard (2), Luc Lorgis (1), Philippe Buffet (1), Maud Maza (1), Claude
Touzery (1), Marianne Zeller (3), Yves Cottin (1)
(1) CHU Bocage, Cardiologie, Dijon, France – (2) CHU, REA SIC, Dijon,
France – (3) INSERM U866, LPPCM, Faculté de Médecine, Dijon, France
Introduction: The syntax score (SS) was developed in 2005 by the team
of the Rotterdam Thorax Center to characterize the complexity of the coronary
network by taking into account: 1/ the number of lesions and their impact on
function, 2/ the location of the lesions, and 3/ their complexity. However,
patients in this study had multivessel disease and stable angina. In patients
with acute myocardial infarction (AMI), we aim to study the characteristics of
the SS in diabetic patients and to determine the predictive value of the SS as
compared with the GRACE score for in-hospital death.
Materials and methods: Our study analysed 1107 consecutive patients,
including 873 non-diabetic patients and 234 diabetic patients, hospitalized for
AMI in the intensive coronary care unit of Dijon from September 2011 to
December 2012 and who had undergone coronary angiography. The
SYNTAX and GRACE scores were both calculated for each patient.
Results: Median SS was significantly higher in diabetic patients (11 (4-15)
vs. 8(4-15), p<0.001) than in non-diabetic patients. In multivariable analysis,
three predictive factors for a high SS were found: female (OR=0.62;
95%CI=[0.45-0.89], (p=0.005)); age (OR=1.03; 95%CI=[1.02-1.04], (p<0.001))
and HDL-C (OR=0.28; 95%CI=[0.11-0.72], (p=0.008)). In-hospital mortality
increased significantly with increasing SS score quartiles (Q1: 2.9%, Q2: 2.2%,
Q3: 4.0%, and Q4: 9.7%, p<0.001). SS score was associated with in-hospital
mortality, even after adjustment for confounding factors (GRACE score and left
ventricular ejection fraction).
Conclusion: In acute MI, the SS score is a reliable tool as it provides
objective information on the coronary network and is a prognostic factor in the
short term. Nonetheless, further studies are needed to understand the influence
of risk factors such as diabetes or hyperglycemia on the initial and residual
SS, and to assess the impact of SS on pharmacological and other revascu-
larization strategies. 
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Obstructive sleep apnea in patients with acute myocardial infarction:
an underdiagnosed risk factor
Houssem Boussaid, Habib Ben Ahmed, Imen Hamdi, Youssef Ben
Ameur, Mohamed Rachid Boujnah
Hôpital Mongi Slim, Cardiologie, Tunis, Tunisie
Background: The prevalence of obstructive sleep apnea (OSA) is signi-
ficantly higher in patients with acute myocardial infarction (AMI) than in
the general population. The identiﬁcation of OSA is especially important
because untreated OSA may lead to increased cardiovascular events.
However, OSA remains largely underdiagnosed in our cardiology’s clinical
practice. 
Aim: We sought to assess the prevalence of OSA in patients after MI and
to identify clinical predictors of OSA in this population. 
Methods: This was a prospective study which has included 120 patients hos-
pitalized for ST elevation myocardial infarction, from April 2011 to March 2012. 
All patients have undergone an overnight sleep study using a portable
polygraphy device, in the 15 days following the acute coronary syndrome. The
diagnostic of OSA was considered as apnea-hypopnea index (AHI) of
≥5 events/hour, severe OSA was defined as AHI of ≥30. Subjective daytime
sleepiness was assessed by the Epworth sleepiness scale (EES). All patients
have had an oxygen saturation monitoring in the coronary care unit using a
pulse oxymeter, before undergoing the sleep study.
Results: The study population was up 102 men and 18 women. The mean
age was 58±12 years. Smoking was the major cardiovascular risk factor with
72% of all patients; diabetes and hypertension were represented in 40% and
44% of the population, respectively. 
The prevalence of OSA was 79%. Mean AHI was 15.76±14.93 and
severe OSA was diagnosed in 16% of all patients. None of the OSA positive
patients were previously documented. Multivariate analysis showed that
independent predictive factors for severe OSA were ESS score of ≥4
(OR=28; 95%IC: 8--101), and nocturnal desaturation of <82% (OR=42;
95%IC: 8.86--198.9).
Conclusion: Prevalence of OSA was very high in patients admitted for
acute myocardial infarction. 
ESS score of ≥4 and nocturnal desaturation of <82% were independent pre-
dictive factors for severe OSA.
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Impact of gender on management of acute coronary syndrome. The
ONACI registry
Nelson Teixeira (1), Xavier Jouven (1), Didier Blanchard (1), Marie-
Cécile Perier (2), Genevieve Mulak (3), Martine Gilard (4), Thierry
Lefevre (5), Nicolas Danchin (1), Christian Spaulding (1), Gilles Lemesle (6),
Thomas Cuisset (7), Hervé Le Breton (8), Etienne Puymirat (1)
(1) Hôpital Européen Georges Pompidou (HEGP), Cardiologie, Paris,
France – (2) Unité INSERM U970, Paris, France – (3) Société Française
de Cardiologie, Paris, France – (4) CHU Brest, Brest, France – (5) Insti-
tut hospitalier Jacques Cartier, Massy, France – (6) Regional and Univer-
sity Hospital of Lille, Lille, France – (7) Hôpital la Timone , Marseille,
France – (8) CHU Rennes, Cardiologie, Rennes, France
Background: Several data suggest that management of acute coronary
syndromes (ACS) could be different according to gender.
Aim: To evaluate the impact of gender on management of ACS from the
ONACI registry.
Methods: ONACI is a national, prospective, multicenter registry. We
focused on data between 2004 and 2008. We evaluated baseline clinical char-
acteristics, angiographic results and management according to type of gender
and, to type of ACS (ST-elevation myocardial infarction STEMI; non- ST-ele-
vation myocardial infarction, NSTEMI).
Results: A total of 19,956 STEMI and 44,974 NSTEMI were included (mean
age 62.7±13.9 and 60.7±12.7 years; 77 and 72% of men, respectively). Overall
women were older and had a higher cardiovascular risk-profile. Proportion of
normal coronary angiography or not significant stenosis (<50%) was higher
among women whatever the type of ACS. Women were less revascularized (by
percutaneous coronary intervention (PCI) or coronary artery bypass ) than men
whatever the class age: 93.7 vs 95.6% (<60 years), 92.5 vs 94.4% (60-74 years)
et 91.9 vs 92.1 (>75 years) for STEMI patients; 86.4 vs 80% (<60 years), 84.2 vs
81.4% (60-74 years) et 80,1 vs 79,4% (>75 years) for NSTEMI patients. In-hos-
pital complications were higher in women in term of death (3 vs. 1% for the
STEMI; 0.4 vs. 0.2% for the NSTEMI) and bleeding complications.
Conclusions: Our results showed that several differences exist for manage-
ment of ACS according to gender especially regarding myocardial revascu-
larisation. Compared to men, women were less revascularized, and had more
in-hospital complication after PCI.
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Influence of the control of cardiovascular risk factors on silent myo-
cardial ischemia and silent coronary stenoses in asymptomatic type 2
diabetic patients
Paul Valensi (1), Antoine Avignon (2), Ariane Sultan (2), Minh Tuan
Nguyen (1), Emmanuel Cosson (1)
(1) Hôpital Jean Verdier, Bondy, France – (2) CHU Montpellier, Diabé-
tologie Nutrition, Montpellier, France
Silent myocardial ischemia (SMI) is a common complication of diabetes.
SMI may be due to functional coronary disorders and/or coronary stenoses
(CS). We hypothesized that control of cardiovascular risk factors (CVRF) at
the time of investigation would be associated with a lower prevalence of SMI.
A total of 1627 asymptomatic type 2 diabetic patients with at least one addi-
tional CVRF were screened for SMI with stress and/or dipyridamole myocardial
scintigraphy. SMI was detected in 412 patients (25.3%); a coronary angiography
was performed in 298 of those with SMI and found CS in 131 patients (44%). The
patients were classified according to control of blood pressure (≤140/90mmHg),
HbA1c (≤7.5%), LDL cholesterol (≤2.6mmol/l) and triglycerides (≤2.3mmol/l).
SMI prevalence was inversely associated with the number of controlled CVRF
(39.6%, 35.7% 24.7%, 19.8%, 17.7% in patients with none, 1, 2, 3 or 4 controlled
CVRF, respectively; p<0.001). In multivariate analysis taking into account the
number of controlled CVRF (3 or 4 vs 0-2), age, diabetes duration, gender, reti-
nopathy, nephropathy, smoking, HDL cholesterol, peripheral vascular disease,
SMI was associated with a lower number of controlled CVRF (odds ratio
0.53[95CI 0.39-0.74]), male gender (2.4[1.8-3.3]) and peripheral vascular disease
(1.6[1.02-2.5]). Among the patients with SMI, the prevalence of CS was lower in
the patients with 3-4 controlled CVRF than in those with 0-2 controlled CVRF
(34.5 vs 47.7%, p<0.05), even after multivariate analysis.
In conclusion, in patients with type 2 diabetes, SMI is markedly lower and
is less concordant with CS when the number of controlled CVRF is higher,
even after adjustment on confounders. This strongly suggests the preventive
efficacy of CVRF control on silent coronary artery disease.
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Coronary microvascular dysfunction in type 2 diabetic patients
assessed with velocity-encoded cardiovascular magnetic resonance of
the coronary sinus at baseline and in response to cold pressor test
Jonathan Dupont (1), Alexis Jacquier (2), Frank Kober (3), Jacques
Quilici (1), Bénédicte Gaborit (4), Jean-Louis Bonnet (1), Maxime
Guye (3), Monique Bernard (3)
(1) Hôpital la Timone, Cardiologie, Marseille, France – (2) Hôpital la
Timone, Radiologie, Marseille, France – (3) Faculté de médecine, Univer-
sité de la Méditerranée, CNRS UMR 6612, Centre de résonance magné-
tique biologique et médical (CRMBM), Marseille, France – (4) Hôpital
Nord, Endocrinologie, Marseille, France
Background: Diabetes mellitus is a well known cardiovascular risk asso-
ciated with structural and functional myocardial alterations, independently of
other known causes of cardiac disease. Current evidence supports an existing
role of microvascular disorder in diabetic cardiomyopathy. The purpose of this
initial study was to assess non invasively microcirculatory alteration and par-
ticularly coronary endothelial function in diabetic patients by myocardial
blood flow (MBF) measurement using coronary sinus (CS) flow quantification
by velocity encoded cine cardiovascular magnetic resonance (CMR) at rest
and during cold pressor test (CPT).
Methods: Twenty-four volunteer men (12 diabetic patients, 12 healthy
control subjects) underwent CMR in a 3 Tesla MR imager. Coronary sinus
flow was measured at rest and during CPT using non breath-hold velocity
encoded phase contrast cine-CMR. Myocardial function and morphology were
acquired using a cine steady-state free precession sequence.
Results: At baseline, mean MBF was 1.22±0.23 ml.g¯ ¹.min¯ ¹ in diabetic
patients and 0.63±0.23 ml.g¯ ¹.min¯ ¹ in nondiabetic population. The rate pressure
product (RPP) is significantly higher in diabetics than controls, at rest. During
CPT, MBF increased significantly in both diabetic and healthy men by
0.53±0.27 ml.g¯ ¹.min¯ ¹ (p < 0.005) and by 0.22±0.19 ml.g¯ ¹.min¯ ¹ (p<0.005),
respectively. The increase in MBF was significantly higher in diabetics than con-
trols (p=0.036) whereas RPP increased similarly in both populations. Coronary
vascular resistance (CVR) and endothelium-dependent vasodilatation index
(EDVI) were not significantly different between the 2 groups in response to CPT.
Conclusion: Elevated baseline blood flow is characteristic of coronary
microvascular dysregulation in diabetic patients. This alteration seems to be
independent of endothelial dysfunction seeing that response of coronary vaso-
dilator function is improved to increased sympathetic stimulation.
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Acute coronary syndrome in giant cell arteritis: case report of
diagnostic dilemma
Sonia Hammami (1), Olfa Berriche (2), Samia Younes (2), M Habib Sfar (2)
(1) Faculté de Médecine Monastir, Nutrition Humaine et désordres méta-
boliques, Monastir, Tunisie – (2) CHU Mahdia, Médecine Interne,
Mahdia, Tunisie
Background: Giant cell arteritis (GCA), also known as granulomatous
arteritis is a systemic vasculitis mainly affecting extra cranial branches of
carotid arteries. It can rarely affect other vascular beds causing thoracic aorta
aneurysm, dissection and rarely cause myocardial infarction through coronary
arteritis. We describe a rare case 
Observation: We report the case of a woman aged 62 years with no history
pathological allowed for significant holo cranial headache. The examination found
weakness and hyperesthesia of the scalp, blood pressure was normal on both arms,
pulse is 74 b/mn. Palpation of the temporal arteries is normal. She present a poly-
myalgia rheumatica. Labs were significant for normochromic normocytic anemia
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(hemoglobin 10.3 g/dL), the erythrocyte sedimentation rate of 120 mm and the
rate of C-reactive protein at 59 mg/l. Serum protein electrophoresis revealed hypo-
albuminemia with a polyclonal hypergammaglobulinemia The lipid profile and
glycemia were normal. A biopsy of the temporal artery confirms the diagnosis of
GCA. The patient diagnosed with GCA according to The American College of
Rheumatology criteria. Before starting treatment, she presented retrosternal chest
pain type of oppression with recurrent pain an hour later. The electrocardiogram
shows an initial regular sinus rhythm at 75 beats/mn, a left axis deviation and dis-
crete disorders of repolarization with elevated cardiac biomarkers (troponinémie to
0.57 ug / l). In the context of acute myocardial ischemia, the patient received treat-
ment with aspirin and heparin with steroid treatment 1 mg/kg/day with a good
evolution. coronary angiography was normal
Conclusion: GCA is an inflammatory arteritis affecting the elderly. Car-
diac symptoms of GCA are unusual requires vigilance and special care
involving specific treatment associated to corticosteroids. Diagnosis and corti-
costeroid treatment should be based on high clinical suspicion
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Obstructive sleep apnea in patients with acute myocardial infarction:
an underdiagnosed risk factor
Houssem Boussaid (1), Habib Ben Ahmed (1), Imen Hamdi (2), Mohamed
Rachid Boujnah (1)
(1) Hôpital Mongi Slim, Service de Cardiologie, Tunis, Tunisie – (2) Hôpi-
tal militaire de Tunis, Service de Cardiologie, Tunis, Tunisie
Background: The prevalence of obstructive sleep apnea (OSA) is signifi-
cantly higher in patients with acute myocardial infarction (AMI) than in the
general population. The identiﬁcation of OSA is especially important because
untreated OSA may lead to increased cardiovascular events. However, OSA
remains largely underdiagnosed in our cardiology’s clinical practice. 
Aim: We sought to assess the prevalence of OSA in patients after MI and
to identify clinical predictors of OSA in this population. 
Methods: Our study was a prospective study which has included
120 patients hospitalized for ST elevation myocardial infarction, from
April 2011 to March 2012. 
All patients have undergone an overnight sleep study using a portable
polygraphy device, in the 15 days following the acute coronary syndrome. The
diagnostic of OSA was considered as apnea –hypopnea index (AHI) of
≥5events/hour, severe OSA was defined as AHI of ≥30. Subjective daytime
sleepiness was assessed by the Epworth sleepiness scale (EES). All patients
have had an oxygen saturation monitoring in the coronary care unit using a
pulse oxymeter, before undergoing the sleep study.
Results: The study population was up 102 men and 18 women. The mean
age was 58±12 years. Smoking was the major cardiovascular risk factor with
72% of all patients. Diabetes and hypertension were represented in 40% and
44% of the population, respectively. 
The prevalence of OSA was 79%. Mean AHI was 15.76±14.93 and severe
OSA was diagnosed in 16% of all patients. None of the OSA positive patients
were previously documented. Multivariate analysis showed that independent
predictive factors for severe OSA were ESS score of ≥4 (OR=28; 95% IC: 8-
–101), and nocturnal desaturation of <82% (OR=42; 95% IC: 8.86--198.9).
Conclusion: Prevalence of OSA was very high in patients admitted for
acute myocardial infarction. ESS score of ≥4 and nocturnal desaturation of
<82% were independent predictive factors for severe OSA.
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Differences of exercise versus everyday activity angina as regards predic-
tion of myocardial viability in patients with ischemic cardiomyopathy
Andreas Karydas (1), Maria Koutelou (1), Athanasios Theodorakos (1),
Athanasios Dritsas (1), Demosthenes Panagiotakos (2), Gregory Pavlides (1),
Dennis Cokkinos (3)
(1) Onassis Cardiac Surgery Center, Cardiac Surgery, Athens, Grèce –
(2) Harokopio University, Dept of Nutrition and Dietetics –, Athens,
Grèce – (3) BRF Academy of Athens, Clinical Research, Athens, Grèce
Background: We prospectively evaluated post myocardial infarction (MI)
of exertional angina (Ang) association with the presence of myocardial via-
bility (VIA) during exercise testing or at everyday activities.
Methods: Fifty-five patients (pts) with a low (≤40%) left ventricular
ejection fraction (LVEF) due to a previous MI were prospectively examined
with stress thallium-201 scintigraphy (Tl-201) for the presence of VIA and
asked for occurrence of Ang and its severity (Borg scale) during treadmill-
exercise stress-testing (ETT) and in everyday life, according to the Group B)
Canadian Cardiovascular Society (CCS) angina classification being also
used, respectively.
Results: Viability was detected in 29 pts (53%) (Group – Gr A) and its
absence in 26pts 41%, Mean LVEF was 31(SD 7)% vs 33(SD 8)% (NS) and
the mean number of diseased vessels was 2.8(SD 1.6) vs 1.9(SD 1.3) (NS) for
Gr A and B respectively. Five pts from each Gr reported Ang during the ETT
(17% vs 21% INS). The Borg scale did not differ among groups. The CCS
score was 1.7(SD 0.8) vs 1.3(SD 0.6) in Gr A and B respectively (p<0.05).
Moreover, a CCS score ≥2 was more frequently associated with VIA (71% vs
41%, p<0.03) and significantly with greater Tl201 reversibility indices (stress
defect, p<0.04, total myocardial mass, p<0.02).
Sensitivity of ANG at ETT to detect VIA was estimated at 5/29 or 17%
and specificity at 21/26 or 81%. The Positive predictive value is 5/10 or 50%
and the negative 21/45 or 47%.The respective values for everyday angina
were 52,77, 71 and 59%.
Conclusion: Viability was not statistically significantly related to anginal
symptoms during ETT but only during everyday life. However, this relation-
ship was weak and thus the belief that anginal pain accurately indicates viable
myocardium, cannot be supported and warrants VIA evaluation in every
patient with ischemic cardiomyopathy.
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Correlation between carotid intima-media thickness and risk factors
of atherosclerosis in patients with type 2 diabetes mellitus
Sana Fennira (1), Narjess Khelifi (2), Soussen Antit (2), Kamilia Ouneissa (3),
Samira Blousa (3), Sondos Kraiem (2)
(1) Hôpital Habib Thameur, Cardiologie, Tunis, Tunisie – (2) Hôpital
Habib Thameur, Tunis, Tunisie – (3) Institut national de nutrition, Tunis,
Tunisie
Background: Carotid intima-media thickness (CIMT) has received interest
as a predictor of cardiovascular events in type 2 diabetes mellitus in recent
years. Factors associated with carotid atherosclerosis are unclear in type 2 dia-
betic patients.
Objective: The aim of this study is to determinate the association of
CIMT with risk factors of atherosclerosis in patients with type 2 diabetes
mellitus.
Methods: Prospective study conducted between November 2011 and
February 2012. It involved 81 type 2 diabetic patients with a mean age of
53±7.9 years [36 ; 70]. 60.5% of patients were females. All patients were
asymptomatic diabetes without known macrovascular complications. A clin-
ical examination, laboratory tests and measurement of CIMT by echography
ultrasound were performed in all patients.
Results: The mean carotid intima-media thickness was 0.74±0.13 mm.
This parameter was positively correlated with older age (p=0.009) and it’s
not influenced by sex neither history family of diabetes, history family of
cardiovascular disease and current-past smoking.  CIMT increased with
diabetes duration (p=0.4), BMI (p=0.97), waist circumference (p=0.4),
fasting glycemia (p=0.9), hypertension (p=0.4), hypercholesterolemia
(p=0.9), hypertriglyceridemia (p=0.8), a lower level of high-density lipo-
protein cholesterol (p=0.4), a higher level of low-density lipoprotein cho-
lesterol (p=0.4) and microalbuminuria (p=0.02). CIMT was independent
from hemoglobin A1c level, postprandial glycemia and ultrasensitive C
reactive protein. 
Conclusion: The prevalence of type 2 diabetes is increasing globally and
poses a heavy burden on public health and socioeconomic development of
all nations. Type 2 diabetes is a multifactorial disease and due to a combi-
nation of environmental and genetic risk factors. Our findings indicate the
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necessity of a best control of fasting glycemia, hypertension, dyslipidemia
and keeping an ideal BMI to avoid the progression of CIMT and so the
cardiovascular risk.
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Differential changes of cardiac biomarkers and lipid profile by gender
in patients with acute myocardial infarction accompanied with non-
alcohol steatohepatites 
Larysa Zhuravlyova, Maryna Filonenko
Kharkiv National Medical University, Internal Medicine N3, Kharkiv,
Ukraine
Diagnosis and risk assessment of acute coronary syndrome in women has
traditionally been more difficult, especially when taking into consideration the
presence of metabolic disorders associated with non-alcoholic steatohepatitis
(NASH).
The purpose of the research was to determine the gender peculiarities of
cardiac biomarkers and lipid profile changes in patients with non-Q wave
myocardial infarction (NQMI) accompanied with NASH.
Methods: 32 men and 30 women with NQMI accompanied with NASH
were examined. All women had menopause. The amount of troponin, cre-
atinekinase-MB (CKMB), transaminases, C-reactive protein (CRP) was deter-
mined in blood of all patients. Blood lipid test was done. Also the data of liver
ultrasound and liver biopsy were analyzed. 
Results: Men with NQMI accompanied with NASH had reliably higher
level of troponin I (+21.8%, 27.2±4.07 ng/ml, p=0.006) and CKMB (+16.9%,
176.7±22.8 units/L, p=0.012)than women. However, women had significantly
higher level of CRP (+31.7%, p=0.014) than men. Disorders of blood lipid
profile were determined in patients of both groups. However, women had reli-
ably higher level of cholesterol (+13,4%, p=0,025), triglycerides (+24,8%,
p=0,003) and low-density lipoproteins (+13.7%, p=0.016). Besides, the level
of high-density lipoproteins in women was lower than in men (–17.3%,
p=0.035).
Conclusions. In patients with NQMI accompanied with NASH, there was
a different expression of cardiac biomarkers. Men had higher levels of CKMB
and troponins, whereas women were more likely to have elevated CRP. This
suggests that a multimarker approach may help to access the initial risk of
NQMI in patients with NASH, especially in women. More significant
derangements of lipid profile in women suggest the need in more intensive
hypolipidemic therapy.
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Clinical and therapeutic specificities of myocardial infarction in
patients with peripheral arterial disease
Naouar Benyassine, Salwa El Karimi, Mostapha El Hattaoui
CHU mohamed XI, Cardiologie, Marrakeh, Maroc
Objective: Several studies underlined the worse prognosis of myocardial
infarction (MI) among patients with peripheral arterial disease (PAD).We
sought to describe the presentation and management modalities of a cohort of
PAD patients presenting an acute MI, compared to those without PAD.
Materials and methods: we conducted a retrospective study, spread over
15 months: January 2012-March 2013, including all patients hospitalized in
the intensive care unit for ACS
Results: Among the 151 patients included, PAD was reported in 81 sub-
jects. In multivariate analysis, the following factors were positively related to
the presence of PAD (P≤0.05): age >75 y (OR=2.3), diabetes (OR=2.0),
hypertension (OR=1.4), active smoking (OR=4.6), renal failure (OR=3.1), and
treatments with antiplatelets (OR=3.9), anti-vitamin K (OR=1.9), statins
(OR=1.7) and low molecular weight heparins (OR=6.8). By introducing the
data concerning the arrival in CCUs in the model, the following factors were
also significantly more frequent among PAD patients: male sex (OR=1.6),
past history of coronary artery disease (OR=2.2), left bundle branch block
(OR=1.8) and late management >6 hours (OR=1.4). Conversely, ST-segment
elevation was less frequent (OR=0.7). When the CCU stay data were intro-
duced in the model, a lower rate of coronary stenting (OR=0.7) and beta-
blockers use within 48 hours of admission (OR=0.6) were noted.
Conclusion: Beyond the presence of PAD per se, several particularities do
exist, especially the coexistence of a high number of pejorative factors and an
under-utilization of treatments presenting prognostic benefits.
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Plasma matrix metalloproteinases concentrations are associated with
the presence and severity of coronary artery disease
Yosra Zayani (1), Monia Elasmi (1), Wiem Zidi (1), Amira Zaroui (2),
Moncef Feki (1), Sami Mourali (2), Rachid Mechmeche (2), Naziha Kaa-
bachi (1)
(1) CHU la Rabta, Biochimie, Tunis, Tunisie – (2) Explorations Fonction-
nelles, Cardiologie, Tunis, Tunisie
Background: Matrix metalloproteinases.(MMPs) expression is related
with the classical cardiovascular risk factors. They play a central role in ath-
erosclerosis, plaque formation, platelet aggregation and coronary artery dis-
ease. The present study aimed to elucidate whether or not plasma MMP-3,
MMP-8 and MMP-9 concentrations are associated with the presence and
severity of coronary artery disease (CAD).
Subjects and methods: 408 patients undergoing coronary angiography for
coronary artery disease (CAD: >50% stenosis), which was found in
116 patients. All biochemical analyses were carried out using a Hitachi 912
analyzer (Roche). MMP-3, MMP-8, MMP-9 and Tissue inhibitor of metallo-
proteinase-1 (TIMP-1) levels were determined in citrate plasma by ELISA
methods.
Resultats:  In 116 patients with CAD, 23.1% had 1-vessel, 14.5% had
2-vessel, and 19.8% had 3-vessel disease. . Compared with 292 patients
without CAD, the 116 with CAD had higher MMP-3, MMP-9 and TIMP-1
concentrations (p<0.001 for MMP-3 and MMP-9) and (p<0.01 for TIMP-1).
There was a stepwise increase in MMP-3, MMP9 and TIMP1 concentration
depending on the number of stenotic vessels: (p<0.001 for MMP-3) and
(p<0.01 for MMP-9 and TIMP-1).
Conclusion: Plasma MMP-3, MMP-9 and TIMP-1 concentration are asso-
ciated with the presence and severity of CAD.
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Association between erectile dysfunction and coronary artery disease
in Tunisian men
Tounsi Ahmed, Jerbi Bassem, Abid Leila, Hentati Mourad, Kammoun
Samir
CHU Hédi Chaker, Service de Cardiologie, Sfax, Tunisie
Introduction: Erectile dysfunction (ED) and coronary artery disease
(CAD) often share common risk factors, and there is growing evidence that
ED might serve as a clinical marker for cardiovascular disease. Despite rising
trends of CAD in Tunisian, limited data are available on the prevalence of ED
and its correlation with CAD severity in such patients.
Aim: To study the prevalence of ED in Tunisian patients undergoing cor-
onary angiography and to assess if the severity of ED correlates with angio-
graphic severity of CAD.
Methods: Tunisian men with CAD documented by angiography were eval-
uated for ED. Erectile function was assessed by a 5-item version of the Inter-
national Index of Erectile Dysfunction.
Main Outcome Measures and Results: Among 118 male patients, ED
was present in 62.7%; patients with ED had a higher incidence of multivessel
CAD (77.5% vs. 50%, P 0.01), diffuse CAD (76% vs. 52.4%, P 0.02), and
higher number of mean coronary vessels involved compared with those
without ED. Those with severe ED had higher prevalence of multivessel CAD
and higher number of mean coronary vessels involved compared with those
with milder grades of ED. Onset of symptoms of ED preceded symptoms of
CAD by a mean of 22.8 months in 66.1% of patients. The presence of severe
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ED was associated with a higher risk of having triple-vessel disease and a
higher risk of having diffuse angiographic CAD 
Conclusion: Patients with angiographic CAD frequently have ED; symp-
toms of ED precede that of CAD in most patients. Incidence of multivessel
and diffuse CAD is significantly more common in patients with ED. It is
important for physicians to be aware of the close relationship between the two
conditions so that patients with ED can have optimal risk stratification for
concomitant CAD whenever required.
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Relation between hemoglobin level and recurrent myocardial ische-
mia in non–ST elevation acute coronary syndromes: Algerian expe-
rience
Hocine Foudad, Ilyas Bouaguel, Rachid Merghit, S Boutamine, Aziz
Trichine, Amor Bouferrouk
Hôpital militaire Constantine, Service Cardiologie, Constantine, Algérie
Introduction and objectives: Anemia at hospital admission predicts a
poor outcome in patients presenting with acute coronary syndrome. However,
the underlying pathophysiologic mechanisms have not been
Well elucidated: The objective of this study was to determine an indepen-
dent relation between the hemoglobin level and recurrent ischemia in patients
with non–ST-segment elevation ACS.
Methods: This retrospective study involved 242 non–ST-segment eleva-
tion Acute Coronary Syndromes patients who were admitted during 2012. The
hemoglobin level was recorded on admission.
We stratified the study population according to their hemoglobin level on
presentation. The primary outcome of the study was recurrent ischemia,
defined as symptomatic or asymptomatic ST-segment shifts on electrocardio-
graphic monitoring. 
Results: Of the 242 patients, 22 had a baseline hemoglobin level <120 g/L,
85 had a level of 120 to 139 g/L, 118 had a level of 140 to 159 g/L, and
17 had a level >160 g/L. The corresponding rates of recurrent ischemia were
46.1%, 21.6%, 16.1%, and 10.9% (p for trend <0.001). A lower hemoglobin
level was associated with advanced age, co-morbidities, and a higher risk
score. In multivariable analysis adjusting for these confounders, lower hemo-
globin levels retained a significant independent association with recurrent
ischemia. 
Conclusions: In conclusion, a lower hemoglobin level at presentation was
independently associated with recurrent ischemia detected by electrocardio-
graphic monitoring in the setting of non–ST-segment elevation ACS.
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Impact of left ventricular systolic function on the prognostic signifi-
cance of atrial fibrillation following acute myocardial infarction
Hocine Foudad (1), Ilyas Bouaguel (1), Rachid Merghit (1), S Bouta-
mine (1), Aziz Trichine (1), Amor Bouferrouk (1), Abdelmoumene
Mekarnia (2)
(1) Hôpital militaire Constantine, Service Cardiologie, Constantine, Algé-
rie – (2) HCA, Cardiologie, Alger, Algérie
Introduction and objectives: Reports on the prognostic importance of
atrial fibrillation following myocardial infarction have provided considerable
variation in results. Thus, this study examined the impact of left ventricular
systolic function on the prognostic importance of atrial fibrillation in acute
myocardial infarction patients.
Methods: The study population was 276 patients consecutively admitted to
hospital with acute myocardial infarction during 2010-2012 in military hospi-
tals of Constantine and Algiers. Informations on the presence of atrial fibrilla-
tion, left ventricular systolic function were prospectively collected. Mortality
was followed for 1 year.
Results: In patients with left ventricular ejection fraction <35%, atrial
fibrillation was associated with an increased in hospital mortality (p<0.001)
and an increased 30-day and 1 year mortality.In-hospital,30-day and 1 year
mortality was not increased in patients with left ventricular ejection frac-
tion>35% and atrial fibrillation. 
Conclusions: Atrial fibrillation is associated with increased in-hospital and
long-term mortality only at the patients with left ventricular dysfunction (left
ventricular ejection<35%) in our study.
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Use of the multilayer flow modulator stent as an endovascular alter-
native treatment in patients with high risk thoracoabdominal aneu-
rysm
Radi Cheaito (1), Yves Louvard (1), Philippe Garot (2), Marie-Claude
Morice (1), Thierry Unterseeh (2)
(1) Institut hospitalier Jacques Cartier, Institut Cardiovasculaire Paris
Sud, Massy, France – (2) Hôpital Privé Claude Galien, Institut Cardio-
vasculaire Paris Sud, Quincy, France
Background: Treatment of thoracoabdominal aneurysm (TAA)  by either
conventional surgery or covered stents is associated with a high rate of morbi-
mortality. Implantation of flow modulating multilayer stents (MLS) is a recent
alternative treatment which allows differed exclusion of the aneurysmal sac
after thrombosis formation, without any risk of occluding an arterial branch
arising from the TAA.
We report our preliminary experience in the treatment of TAA with MLS
Methods: Between April 2010 and April 2013, 4 patients included in the
STRATO trial and presenting with high surgical risk TAA were treated by
percutaneous implantation of MLS in the interventional cardiology department
of the Hôpital Privé Claude Galien
Results: Four patients (75% female, mean age 81.7 yrs (range: 73-89), pre-
senting with TAA (Crawford type II: 75% ; Type III: 25%) were treated by
percutaneous MLS (100% transfemoral with 22-fr catheters)
Mean aneurysm diameter was 68.8 cm (min: 55.5 – Max: 83.2). Procedural
success was 100%; mean contrast volume: 184.75 ml (Min 120 – Max: 250);
total X-ray dose: 109.91 Gy.cm2 (min: 48.56 – max: 200); percutaneous clo-
sure in 75%. A mean of 1.25 MLS were implanted per patient. 
Mean hospital stay was 8 days and CT-scan examination at discharge
confirmed appropriate MLS position and absence of collateral branch occlusion.
At 12 months’ follow-up, (clinical and CT-scan), survival rate was 100%
with 100% collateral branch patency and a 9.5% decrease in the size of the
aneurysmal sac. Updated follow-up results will be available for the meeting. 
Conclusion: Use of MLS seems a safe and efficient alternative to current
treatment modalities of high-risk TAA, allowing differed exclusion of the
aneurysmal sac and preservation of the collateral branches.
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Retrospective analysis of coronary angiography in patients with coro-
nary artery disease acording to metabolic statuts
Larysa Zhuravlyova] (1), Natalia Lopina (1), Inna Demchenko (2)
(1) Kharkiv National medical university, internal medicine N3, Kharkiv,
Ukraine – (2) Kharkiv Regional Hospital, Cardiologic, Kharkiv, Ukraine
Purposes: To provide retrospective analysis of coronary angiography in
patients (pts) with coronary artery disease (CAD) according to the metabolic
status. 
Materials and methods: We provide a retrospective analysis of 90 cases
of pts with CAD (54 males, aged 60,5±4,7 years). Baseline characteristics of
pts included history of CAD (7,2±2,3 years), type 2 diabetes mellitus – T2DM
(4,7±0,5 years). All pts were divided into 2 groups: 1st group (1gr) - pts with
concomitant T2DM (n=30), 2nd group(2gr) (n=60) - pts without T2DM. The
levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL),
very LDL (VLDL), triglycerides (TG), high-density lipoprotein cholesterol
(HDL), fasting blood glucose and level of HbA1c were determined. The pres-
ence and extent of CA occlusion were performed using coronary angiography.
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Results: Among 1gr of pts in 47% cases (n=14) registered atherosclerotic
lesion of two CA and in 26% (n=8) lesion of three CA compared with the
18% (n=11) and 7% (n=4) respectively in the 2 gr (p<0.05).  Lesion of one
CA among pts of 1gr registered in 20% (n=6) cases compared with 67%
(n=40) cases among 2gr (p<0.05). CA lesion among 1gr of pts has been local-
ized in the middle and distal segments of CA in 64% of cases compared with
20% in the 2gr (p<0.05). The degree of occlusion of the CA was significantly
higher in the 1gr in which rates of TC, LDL cholesterol, TG, HbA1c were the
highest. The level of HbA1c positively correlated with the degree of CA
occlusion (p=0.38, p<0.05). We also evaluated correlation between the degree
of CA occlusion and the level of LDL cholesterol (r=0.56, p<0.05), and TG
levels (r=0.49, p<0.05).
Conclusions: Among pts with CAD and T2DM most frequently register
diffuse and widespread CA injury, multivessel lesions which mainly localized
in the middle and distal segments of CA. These changes were associated with
significantly higher levels of LDL cholesterol, TG and lower HDL cholesterol,
and parameters of carbohydrate metabolism.
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The coronary artery disease in Moroccan women: what strategy to
support?
Fatima Wadrahmane, Roger Kokusa
CHU Ibn Rochd Casablanca, Cardiologie, Casablanca, Maroc
Aims: The cardiovascular risk in women increases with age to join the car-
diovascular risk in men; it is the leading cause of mortality. In Morocco as in
developing countries the coronary artery disease in women is increasing and
its management remains inadequate.
Methods and results: We report a retrospective study conducted at the
cardiology center at the University Hospital IBN Rochd of Casablanca in
Morocco from January 1, 2008 to January 1, 2013, this study concerned
2300 patients.
Women represent 31.8% of all coronary managed in the service. The
average age was 62.3 years, 70% postmenopausal, 46% hypertensive, 30%
diabetic, 14% had renal failure at the stage of hemodialysis, and 10% have
already done an ischemic stroke.
67% of our patients had an LV EF ≥50%. 48.97% were thrombolysis H12
before the pain.
16% had complete revascularization with 4.77% in the acute phase,
720 angioplasty were performed with 96-eluting stents.
Conclusions: The female population coronary presents real differences
with the male population with a poorer prognosis even after an invasive pro-
cedure. Several reasons are advanced to explain this difference: higher average
age, the higher proportion of diabetics and the diameter of coronary vessels
smaller in the female population.
In our Moroccan context the coronary artery disease in women is indeed
very common but remains under diagnosed and under treated because of the
non-Public Education and interventional cardiology centers that do not cover
the entire territory of Morocco.
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Combination of copeptin and high-sensitivity cardiac troponin T
assays for faster diagnosis of non-ST-segment acute coronary syn-
drome in low risk patients in the emergency department
Emilie Bohyn (1), Komlavi Yayehd (2), Eulophe Dubie (3), Christophe
Lebrun (1), Jerome Jund (4), Gaspard Beaune (1), Mathieu Chacornac (2),
Dominique Savary (4), Patrick Lessage (3), Loic Belle (4) 
(1) SAMU, Annecy, France – (2) Cardiologie, Annecy, France – (3) SAMU
Chambéry, Chambéry, France – (4) Hôpital, RENAU, Annecy, France
Purpose: Guidelines recommend repeating measurement of cardiac tro-
ponin 6-12 h after admission, or high-sensitivity cardiac troponin T (hs-TnT)
3 h after admission, to establish a diagnosis in patients with suspected non-ST-
segment elevation myocardial infarction (NSTEMI). We hypothesized that a
combination of negative copeptin (<14 pmol/l) and hs-TnT (<14 ng/l) in addi-
tion to low GRACE risk score (<108) could be used to rule out the diagnosis
of non-STsegment elevation acute coronary syndrome (NSTE-ACS) in
patients with chest pain presenting to the emergency department (ED).
Methods: This observational prospective study included consecutive
patients (>18 y) admitted to EDs for chest pain of <6 h duration and suspected
NSTE-ACS. Patients with ST-segment elevation myocardial infarction were
excluded. All patients underwent clinical examination with GRACE risk score
assessment, initial ECG registration and early copeptin/hs-TnT measurement.
The diagnosis of NSTE-ACS was made retrospectively, based on clinical,
ECG, biological, stress tests and coronary angiogram data.
Results: Of the 247 patients enrolled, 50 (20.4%) had NSTE-ACS
(39 NSTEMI, 11 unstable angina) and 195 (78.9%) had a non-coronary diag-
nosis. The negative predictive value of the combination of hs-TnT <14 and
copeptin <14 was 95% (95%CI, 90-98), and reached 99% (95%CI, 94-100)
with the combination of hs-Tn, copeptin and GRACE risk score (Table).
Conclusion: The combination of early negative copeptin and hs-TnT and
low GRACE risk score could be used to rule out a diagnosis of NSTE-ACS
in patients with suspected chest pain presenting to EDs.
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Factors associated with early coronary atherosclerosis evolution
during a 18-month follow-up after a first acute coronary syndrome
Florence Loeb, Sophie Tassan-Mangina, Benoit Hercé, Pierre Nazeyrollas,
Damien Metz
CHU Reims, Cardiologie, Reims, France
Introduction: evolution of coronary artery disease differs among patients,
even if the treatment is optimal. The aim of our study was to search for pre-
dictors of early worsening of coronary atherosclerosis after a first acute coro-
nary syndrome.
Material and methods: patients who underwent a coronary angiography for a
first acute coronary syndrome between January 2008 and December 2011 and had
a follow-up in our institution were retrospectivly included. Event was defined as
recurrent ischemia due to worsening of the coronary artery disease during the fol-
lowing eighteen months, confirmed by coronary angiography and excluding intra-
stent restenosis. Cardiovascular risk factors, biology, data derived from
echocardiography and coronary angiography were collected. A Kaplan-Meier sur-
vival analysis was performed using log-rank test and Cox model.
Results: one hundred and fifteen patients were included. All patients had
an optimal percutaneous revascularisation and a medical treatment according
to current guidelines. STEMI accounted for 69% of patients and 40% had a
multivessel coronary artery disease. During follow-up, 26 patients (23%) had
an early symptomatic coronary evolution. Significant risk factors in univariate
analysis were age (p=0.018), history of coronary artery disease in 1st degre
relative (p=0.03), peripheral vascular disease (p=0.001), NSTEMI (p=0.007),
multivessel disease (p=0.008) and initial incomplete revascularisation
(p=0.008). In multivariate analysis, family history of coronary artery disease
(OR=2.7 [1.1-6.6]; p=0.031), NSTEMI (OR=2.7 [1.1-6.8]; p=0.036) and
multivessel coronary artery disease (OR=4.2 [1.2-14.1]; p=0.02) were inde-
pendantly associated with worsening of coronary atherosclerosis.
Table. Diagnostic accuracy to detect NSTE-ACS
[Data are% (95% CI)]






hs-TnT <14 and 
GRACE score <108
88 (76-97) 72 (65-78) 45 (35-55) 96 (91-98)
hs-TnT <14 and 
Copeptin <14
90 (79-96) 53 (46-60) 33 (26-41) 95 (90-98)
hs-TnT <14 and 
Copeptin <14 and 
GRACE score <108
98 (90-100) 46 (39-53) 32 (25-40) 99 (94-100)
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Conclusion: after a first acute coronary syndrome, family history,
NSTEMI as first cardiac event and multivessel coronary disease were inde-
pendantly associated with early symptomatic evolution of coronary disease.
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Primary percutaneous coronary intervention of bifurcation lesions
Bassem Rekik, Rania Hammami, Leila Abid, Abdelkader Maalej, Souad
Mallek, Dorra Abid, Mourad Hentati, Samir Kammoun
CHU Hédi Chaker, Service de Cardiologie, Sfax, Tunisie
Introduction: There are little data regarding the outcomes of bifurcation
stenting during the acute phase of stemi, because this group of patient is usu-
ally excluded from trials. 
Methods: In 139 patients who underwent bifurcation stenting, the clinical
characteristics, procedural success, and in-hospital cardiac events were com-
pared retrospectively between the patients with and without stemi. The pci
strategy was at the discretion of the operator.
Results: 41 patients (29, 4%) were hospitalized for stemi and underwent a
bifurcation stenting during a primary pci. Tabagism was significantly more
frequent in patients with stemi. The remaining baseline clinical characteristics
between the 2 groups were similar. The majority of bifurcation lesions (71%)
were seen in the left anterior ascending (lad) artery. The provisional stenting
was more performed in patients with stemi than in the others patients but
without significant difference ( 95,1%vs 83,7%, p=0,06) there were no differ-
ence in the procedural success and the final timi-3 flow, and also in the
1 month, 6 months and 1 year mace between the 2 groups. 
Conclusions: Bifurcation lesions are relatively common in emergent pci
for stemi involving especially the lad. It can be safely treated with a provi-
sional stenting approach, and the immediate and long term outcomes are sim-
ilar to those of stable patients. 
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Percutaneous coronary intervention in Senegal: indications, techniques
and results about 34 cases
Mouhamed Cherif Mboup (1), Massamba Thiam (2)
(1) Hôpital Principal de Dakar, Cardiologie, Dakar, Sénégal – (2) Cli-
nique du Golf, Dakar, Sénégal
Percutaneous coronary intervention with stent  introduced by Sigwart et al
in 1986, remains the treatment of choice for coronary atherosclerotic disease
in its different presentations. However, it is still widely practiced in sub-
Saharan Africa. The aim of this study is to describe the indications, techniques
and results of percutaneous coronary intervention in Senegal.
Methods: We prospectively included all patients who underwent percutaneous
coronary intervention with or without stent implantation between July 2012 and
January 2013. We evaluated the indications of procedures, technical procedures
and results of percutaneous coronary intervention performed in our center.
Results: During the period covered by our work, 34 percutaneous coronary
intervention  were performed in 31 patients. The average age of patients was
60.33±10.8 years. Three patients had underwent coronary angioplasty in
France. The indications of the procedures were dominated by acute coronary
syndromes without ST segment elevation in 19 patients foun. The arterial
acces was radial or femoral respectively in  5 and 29  cases . During the coro-
nary angiography lesions were type B2 / C in 19 patients with TIMI 0 in
9 patients. Procedures were successful in 31 cases with implantation of bare
metal stents  and drug-eluting stents in respectively 30 and 2 cases. A mod-
erate bleeding  was found in one patient.
Conclusion: Percutaneous coronary intervention in low income sub-saha-
rian country is feasible with high success rate and very low complication
despite difficult lesion. Our problems are the availability of a good heart sur-
gery team and the consumables.
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Determinants of improved one-year survival in non-ST-segment eleva-
tion myocardial infarction patients: insights from the French FAST-
MI program over 15 years
Etienne Puymirat (1), Francois Schiele (2), Gabriel Steg (3), Didier Blan-
chard (1), Johanne Silvain (4), Patrick Goldstein (5), Pascal Gueret (6),
Genevieve Mulak (7), Elodie Drouet (8), Vincent Bataille (9), Simon
Cattan (10), Jean Ferrieres (9), Tabassome Simon (8), Nicolas Danchin (1)
(1) Hôpital Européen Georges Pompidou (HEGP), Cardiologie, Paris,
France – (2) CHU Jean Minjoz, Cardiologie, Besançon, France –
(3) Hôpital Bichat-Claude Bernard, Cardiologie, Paris, France –
(4) Hôpital La Pitié-Salpêtrière , Paris, France – (5) CHU Lille,
Urgences, Lille, France – (6) CHU Henri Mondor, Cardiologie, Créteil,
France – (7) Société Française de Cardiologie, Paris, France – (8) Hôpi-
tal Saint Antoine, Cardiologie, Paris, France – (9) CHU Rangueil, Tou-
louse, France – (10) CH Le Raincy-Montfermeil, Montfermeil, France
Background. Improved prognosis in non-ST elevation myocardial infarc-
tion (NSTEMI) patients has been mainly attributed to the invasive strategy but
the long-term benefits are more uncertain.
Objective: To assess the determinants of improved one-year survival in
NSTEMI patients.
Methods: Four 1-month French nationwide registries, conducted 5 years
apart (between 1995, 2000, 2005, 2010), including a total of 3,903 with ele-
vated cardiac markers participated NSTEMI patients admitted to intensive
care or coronary care units. We evaluated changes over time in crude 1-year
mortality and determinants of long term survival.
Results: From 1995 to 2010, no major change was observed in patients'
characteristics in NSTEMI population. Early use of antiplatelet agents, β-
blockers, ACE-I and statins increased gradually (P<0.001); use of anticoagu-
lants over then unfractionated heparin (LMWH, bivalirudine or fondaparinux)
increased from 40.8% in 2000 to 78.9% in 2010 (p<0.001); and, percutaneous
coronary intervention (PCI) ≤3 days of admission rose from 7.6% to 48.1%
(P<0.001). One-year death decreased from 20% to 9.8%: adjusted HR for
2010 vs 1995: 0.49 (0.38-0.63). Early PCI (HR 0.70; 95%CI 0.55-0.90), use
of anticoagulants over then unfractionated heparin (HR 0.61; 95%CI 0.50-
0.74) and appropriate early medical therapy (HR 0.56; 95%CI 0.44-0.72) were
predictors of improved survival.
Conclusion: One-year mortality of NSTEMI patients has decreased by a
spectacular 50% in the past 15 years in France. An increased use of invasive
strategy, together with change in type of anticoagulants and appropriate early
medical treatment were the determinants of improved one-year survival.
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Prevalence, clinical profile and 3-year outcomes of acute myocardial
infarction patients with and without obstructive coronary lesions: The
FAST-MI 2005 registry
Romain André (1), Meyer Elbaz (2), Tabassome Simon (3), Etienne Puy-
mirat (4), Pierre-Vladimir Ennezat (5), Patrick Ohlmann (6), Vincent
Probst (7), Bernard Peltier (8), Jean Ferrières (9), Nicolas Danchin (4)
(1) Toulouse University Hospital, Department of Cardiology, Toulouse,
France – (2) Toulouse University Hospital, Department of Cardiology B, Tou-
louse, France – (3) Hospital Saint Antoine, Department of Pharmacology,
Paris, France – (4) Hôpital Européen Georges Pompidou (HEGP), Cardiol-
ogie, Paris, France- (5) Eaux-Claires Clinic, Department of Cardiology, Gre-
noble, France – (6) Strasbourg University Hospital, Civil Hospital,
Department of cardiovascular surgery, Strasbourg, France – (7) University
Hospital of Nantes, Department of Cardiology, Nantes, France – (8) Regional
Hospital of Ploërmel, Department of Cardiology, Ploërmel, France –
(9) CHU Rangueil, Service de Cardiologie B, Toulouse, France
Objectives: our aim was to describe the clinical profile and to evaluate the
3-year outcome of patients admitted for acute myocardial infarction (AMI)
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